Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a specific type of uterine (womb) cancer called endometrioid endometrial cancer, confirmed through laboratory testing of tissue samples
- People who have completed a hysterectomy (surgery to remove the uterus) along with surgical staging (surgery to determine how far the cancer has spread)
- People whose cancer has been confirmed as Stage III (meaning the cancer has spread beyond the uterus but not to distant parts of the body) according to an international staging system called FIGO
- People who are generally well enough to carry out light daily activities, with little to no restriction from their illness (confirmed with trial site)
- People who have already received, or are planning to receive, chemotherapy after their surgery
Who may not be able to join:
- People whose cancer has spread to distant parts of the body (such as other organs far from the original cancer site)
- People who have previously had radiation therapy to the pelvic area
- People who have a serious or unstable health condition (confirm with trial site)
- People who have a history of another type of cancer, with the exception of thyroid cancer, skin cancer, or endometrial cancer
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Won Park, Samsung Medical Center
Phone: +82-2-3410-2612
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
5-year disease-free survival rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.